Pooja Shivappa

Dr. Pooja Shivappa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Journal of Pharmacy and Bioallied Sciences
Verified
Journal Article
Open access
PSPooja Shivappa
Pooja Shivappa
GBGrisilda Vidya Bernhardt
Grisilda Vidya Bernhardt
Radiation therapy is used as the primary treatment for cancer. Eighty percent of cancer patients require radiation therapy during treatment or for medical purposes. During treatment, radiation causes various biological defects in the cells. The prevalence of cytotoxicity limits the dose used for effective treatment. This method is designed to strike a balance between removing cancer cells and protecting normal tissues. Unfortunately, effective radiation is unavailable once acute toxicity occurs during clinical radiation therapy. Therefore, a lot of research interest is needed in the discovery of radioprotective drugs to accelerate treatment to reduce this toxicity (i.e., normal tissue toxicity to cancer cell death). Radiation protectors may be chemicals or drugs that minimize the damage caused due to radiation therapy in living organisms. The determination of effective and nontoxic radiation protection is an essential goal for radiation oncologists and basic radiobiologists. However, despite the advantages, many radioprotectors were found to have disadvantages which include cost, less duration, toxicity, and effect on the central nervous system. Therefore in recent years, the focus has been diverted to finding out optimal natural products to act as radioprotectors. Natural radiation protectors are plant compounds that protect normal (noncancerous) cells from damage from radiation therapy. Natural herbal products are nontoxic with proven therapeutic benefits and have long been used to treat various diseases. In conclusion, we find that there are various radiation protectors with different purposes and mechanisms of action.

Verified
Journal Article
Open access
PDF file
AWAdil Farooq Wali
Adil Farooq Wali
JPJayachithra Ramakrishna Pillai
Jayachithra Ramakrishna Pillai
STSIRAJUNISA TALATH
SIRAJUNISA TALATH
PSPooja Shivappa
Pooja Shivappa
SSSathvik Belagodu Sridhar
Sathvik Belagodu Sridhar
NANowar Nizar Alani
Nowar Nizar Alani
Extensive investigation has been conducted on plant-based resources for their pharmacological usefulness, including various cancer types. The scope of this review is wider than several studies with a particular focus on breast cancer, which is an international health concern while studying sources of flavonoids, carotenoids, polyphenols, saponins, phenolic compounds, terpenoids, and glycosides apart from focusing on nursing. Important findings from prior studies are synthesized to explore these compounds’ sources, mechanisms of action, complementary and synergistic effects, and associated side effects. It was reviewed that the exposure to certain doses of catechins, piperlongumine, lycopene, isoflavones and cucurbitacinfor a sufficient period can provide profound anticancer benefits through biological events such as cell cycle arrest, cells undergoing apoptosis and disruption of signaling pathways including, but not limited to JAK-STAT3, HER2-integrin, and MAPK. Besides, the study also covers the potential adverse effects of these phytochemicals. Regarding mechanisms, the widest attention is paid to Complementary and synergistic strategies are discussed which indicate that it would be realistic to alter the dosage and delivery systems of liposomes, nanoparticles, nanoemulsions, and films to enhance efficacy. Future research directions include refining these delivery approaches, further elucidating molecular mechanisms, and conducting clinical trials to validate findings. These efforts could significantly advance the role of phytocompounds in breast cancer management.

19 August 2024 in New Emirates Medical Journal
Verified
Journal Article
Open access
PDF file
PSPooja Shivappa
Pooja Shivappa
GBGrisilda Vidya Bernhardt
Grisilda Vidya Bernhardt
PGPriya Gatti
Priya Gatti
VRVijay Radhakrishnan
Vijay Radhakrishnan
: Cancer remains one of the most prevalent diseases, with a high mortality rate, despite advancements in technology and science. Patients diagnosed with cancer typically undergo a traumatic experience, enduring both mental anguish and physical exhaustion. Psychosocial distress is common among cancer patients and can have a detrimental effect on their overall quality of life. Therefore, it is crucial for oncology healthcare professionals to promptly evaluate psychosocial distress in cancer patients to improve their care and well-being. This review provides a concise overview of the extensive literature on the epidemiology of various psychosocial disorders affecting cancer patients, including associated distress and burdens, encountered challenges, pain symptoms, and potential evidence-based interventions or mandates in cancer care. Enhancing patientdoctor communication and providing individualized care to the body and mind are necessary.

Verified
Journal Article
Open access
PDF file
Nada Tawfig HashimNada Tawfig Hashim
Nada Tawfig Hashim
SFSadiah Fathima
Sadiah Fathima
NHNurain Mohammad Hisham
Nurain Mohammad Hisham
PSPooja Shivappa
Pooja Shivappa
MMMichael v. Magaogao
Michael v. Magaogao
MRMuhammed Mustahsen Rahman
Muhammed Mustahsen Rahman
Periodontal disease, characterized by bacterial plaque accumulation and subsequent immune response, can lead to gingivitis and periodontitis if untreated. Salivary alpha-amylase (sAA) has emerged as a potential biomarker with implications in periodontal disease progression. Objectives: This study aimed to assess and compare salivary alpha-amylase levels in individuals with periodontitis and healthy controls and to investigate its relationship with clinical parameters of periodontal disease. Forty-five participants were categorized into periodontally healthy (n = 13), Stage I and II Periodontitis (n = 17), and Stage III and IV periodontitis (n = 15) groups. Saliva samples were collected and analyzed using ELISA kits. Statistical analyses included tests for normality, group comparisons, post hoc analysis, and correlation analysis. Significant differences in salivary alpha-amylase levels were observed among severity groups (p < 0.05), with higher levels in periodontitis patients than healthy controls. Spearman correlation revealed moderate positive associations between alpha-amylase levels and probing depth (PD) and clinical attachment loss (CAL). Elevated salivary alpha-amylase levels were found to be associated with more severe periodontal disease, suggesting its potential as a biomarker for periodontitis severity. These findings support the utility of salivary biomarkers in periodontal disease diagnosis and monitoring, although further validation and standardization are warranted for clinical application.

1 January 2020 in Biomedical and Biotechnology Research Journal
Verified
Journal Article
Closed access
PSPooja Shivappa
Pooja Shivappa
AHAshfaque Hoosain
Ashfaque Hoosain
PRPadmaG.M. Rao
PadmaG.M. Rao
19 patients with diabetes, liver injury, rheumatic diseases, respiratory issues, kidney problems, and breast malignant growth. The various international companies supporting the findings in the treatment/vaccine for COVID-19. There are currently no specific antiviral drugs, however, several antiviral drugs and repurposed drugs are under serious scrutiny. We encourage all readers to continue to assess clinical data as it emerges and shares their experience within our community in a well-controlled and, adequately powered fashion....

28 June 2024 in Veterinary World
Verified
Journal Article
Open access
GBGRISILDA VIDYA BERNHARDT
GRISILDA VIDYA BERNHARDT
KBKavitha Bernhardt
Kavitha Bernhardt
PSPooja Shivappa
Pooja Shivappa
JPJanita Rita Trinita Pinto
Janita Rita Trinita Pinto
Background and Aim: Staphylococcus aureus, with its diverse virulence factors and immune response evasion mechanisms, presents a formidable challenge as an opportunistic pathogen. Developing an effective vaccine against S. aureus has proven elusive despite extensive efforts. Autologous Staphylococcus lysate (ASL) treatment has proven effective in triggering an immune response against bovine mastitis. Peptides that stimulate the immune response can be the subject of further research. The study aimed to use immunoinformatics tools to identify epitopes on S. aureus surface and secretory proteins that can bind to major histocompatibility complex class I (MHC I) and CD8+ T-cells. This method aids in discovering prospective vaccine candidates and elucidating the rationale behind ASL therapy’s efficacy. Materials and Methods: Proteins were identified using both literature search and the National Center for Biotechnology Information search engine Entrez. Self and non-self peptides, allergenicity predictions, epitope locations, and physicochemical characteristics were determined using sequence alignment, AllerTOP, SVMTriP, and Protein-Sol tools. Hex was employed for simulating the docking interactions between S. aureus proteins and the MHC I + CD8+ T-cells complex. The binding sites of S. aureus proteins were assessed using Computer Atlas of Surface Topography of Proteins (CASTp) while docked with MHC I and CD8+ T-cells. Results: Nine potential S. aureus peptides and their corresponding epitopes were identified in this study, stimulating cytotoxic T-cell mediated immunity. The peptides were analyzed for similarity with self-antigens and allergenicity. 1d20, 2noj, 1n67, 1nu7, 1amx, and 2b71, non-self and stable, are potential elicitors of the cytotoxic T-cell response. The energy values from docking simulations of peptide-MHC I complexes with the CD8+ and T-cell receptor (TCR) indicate the stability and strength of the formed complexes. These peptides – 2noj, 1d20, 1n67, 2b71, 1nu7, 1yn3, 1amx, 2gi9, and 1edk – demonstrated robust MHC I binding, as evidenced by their low binding energies. Peptide 2gi9 exhibited the lowest energy value, followed by 2noj, 1nu7, 1n67, and 1d20, when docked with MHC I and CD8 + TCR, suggesting a highly stable complex. CASTp analysis indicated substantial binding pockets in the docked complexes, with peptide 1d20 showing the highest values for area and volume, suggesting its potential as an effective elicitor of immunological responses. These peptides – 2noj, 2gi9, 1d20, and 1n67 – stand out for vaccine development and T-cell activation against S. aureus. Conclusion: This study sheds light on the design and development of S. aureus vaccines, highlighting the significance of employing computational methods in conjunction with experimental verification. The significance of T-cell responses in combating S. aureus infections is emphasized by this study. More experiments are needed to confirm the effectiveness of these vaccine candidates and discover their possible medical uses. Keywords: autologous Staphylococcus lysate therapy, CD8+ T-cell immunity, computational tools, epitopes, immunoinformatics, immunological responses, major histocompatibility complex class I binding epitopes, molecular docking simulations, Staphylococcus aureus, vaccine development.